Cboe UK SEK

Nolato AB (publ) (NOLABS.XC)

51.33
0.00
(0.00%)
At close: April 10 at 3:11:45 PM GMT+1
Loading Chart for NOLABS.XC
  • Previous Close 51.33
  • Open 51.05
  • Bid 48.66 x --
  • Ask 50.30 x --
  • Day's Range 51.33 - 51.33
  • 52 Week Range 51.05 - 51.62
  • Volume 97
  • Avg. Volume 72
  • Market Cap (intraday) 13.873B
  • Beta (5Y Monthly) 0.96
  • PE Ratio (TTM) 21.03
  • EPS (TTM) 2.44
  • Earnings Date --
  • Forward Dividend & Yield 1.50 (2.92%)
  • Ex-Dividend Date May 7, 2025
  • 1y Target Est --

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Sweden, Hungary, Asia, Europe, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and dropper bottles. It also provides thermal heating pads, gap fillers, and paste under the Compatherm brand; TreffLab by Nolato that includes Autolys M products, deep well plates, microtubes, PCR/qPCR products, pipettes and slim-line pipette tips, Treff vial HP, and TreffLab quality grades; and electromagnetic compatibility (EMC) products, including Compashield molded and extruded electromagnetic interference (EMI) shielding gaskets, Trishield, and MIL SPEC EMI shielding products. In addition, the company offers laboratory products, such as boxes with integrated lids; containers with hinged lids; sampling and transport tubes; eye rinse cups and dental boxes; spoons and cups; disposable tubes and containers; test tubes and ergonomic caps; and containers, vials, and slide tubes with push on lids. Further, it provides injection molding of plastic and silicone, injection blow molding, scientific and ceramic injection molding, dip and compression molding, and micro molding; extrusion and silicone sponge extrusion technologies; thermal management; decoration, flatbed punching, and die-cutting technologies; cleanroom production; laser-activated bonding and assembly solutions; design and virtual prototyping solutions; and tool manufacturing. It serves the medical technology, pharmaceutical, consumer electronics, telecom, automotive, hygiene, and other industrial sectors. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was founded in 1938 and is headquartered in Torekov, Sweden.

www.nolato.com

5,837

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NOLABS.XC

View More

Performance Overview: NOLABS.XC

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

NOLABS.XC
0.54%
OMX Stockholm 30 Index (^OMX)
3.39%

1-Year Return

NOLABS.XC
3.58%
OMX Stockholm 30 Index (^OMX)
5.68%

3-Year Return

NOLABS.XC
3.94%
OMX Stockholm 30 Index (^OMX)
14.51%

5-Year Return

NOLABS.XC
3.94%
OMX Stockholm 30 Index (^OMX)
58.43%

Compare To: NOLABS.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NOLABS.XC

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    13.87B

  • Enterprise Value

    14.73B

  • Trailing P/E

    21.03

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.43

  • Price/Book (mrq)

    2.41

  • Enterprise Value/Revenue

    1.52

  • Enterprise Value/EBITDA

    9.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.81%

  • Return on Assets (ttm)

    5.95%

  • Return on Equity (ttm)

    12.06%

  • Revenue (ttm)

    9.66B

  • Net Income Avi to Common (ttm)

    658M

  • Diluted EPS (ttm)

    2.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    672M

  • Total Debt/Equity (mrq)

    26.68%

  • Levered Free Cash Flow (ttm)

    585M

Research Analysis: NOLABS.XC

View More

Company Insights: NOLABS.XC

Research Reports: NOLABS.XC

View More